You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table HSR-6. Priority responses to prevent infectious diseases among drug users in 26 EU countries, Norway and Turkey, according to national policies, 2007

Country	Needle and syringe programmes (NSPs)	Voluntary infectious diseases counselling and testing (VCT)	Information materials dissemination (IEC)	Hepatitis vaccination programme	Individual risk assessment and one-to-one counselling	Outreach health education	Provider-driven infectious diseases testing	Training on safer use / safer injecting	Other priority	No Information
Belgium (German community)			Y			Y				Y
Belgium (Flemish community)	Y	Y				Y
Belgium (French community)		Y	Y	Y
Bulgaria	Y	Y					Y
Czech Republic	Y	Y						Y
Denmark	Y			Y			Y
Germany	Y		Y					Y
Estonia	Y	Y	Y
Ireland	Y	Y		Y
Greece				Y	Y		Y
Spain	Y	Y		Y
France	Y	Y	Y
Italy			Y	Y	Y
Cyprus	Y		Y	Y
Latvia	Y	Y			Y
Lithuania	Y	Y			Y
Luxembourg		Y	Y		Y
Hungary	Y	Y	Y
Malta	:	:	:	:	:	:	:	:	:	:
Netherlands	Y		Y	Y
Austria	Y	Y	Y
Poland	Y		Y			Y
Portugal	Y		Y			Y
Romania	Y	Y					Y
Slovenia	Y		Y			Y
Slovakia	Y			Y					Y
Finland	Y			Y		Y
Sweden		Y		Y	Y
United Kingdom	Y		Y				Y
Croatia	:	:	:	:	:	:	:	:	:	:
Turkey		Y					Y	Y
Norway	Y	Y		Y

Notes:

: indicates data not available

Based on the question: "Please tick three responses that are - according to your national policy - considered as priority responses to prevent infectious diseases among drug users."

Multiple choice question with 8 closed and 3 open answer categories.

"Y" indicates that the intervention is regarded as one of the priority responses to prevent drug related health consequences in drug users.

An empty cell does not imply that the response does not exist in the country.

'Other priority' in Slovakia: "Free of charge, easy accessible detoxification, long-term or substitution treatment provision"

Data were not available for Malta and Croatia.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Structured Questionnaire on 'prevention and reduction of health-related harm associated with drug use' (SQ23/29), submitted by NFPs in 2008.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)